The Plasma Metabolomics Profiling of Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 28, 2022

Study Completion Date

May 19, 2023

Conditions
Primary AldosteronismEssential HypertensionIdiopathic AldosteronismAldosterone-producing Adenoma
Interventions
DIAGNOSTIC_TEST

liquid chromatography-mass spectrometry (LC/MS)

Metabolomics is a rapidly evolving high-throughput technology that allows the measurement of the entire complement of metabolites generated by biochemical reactions under certain conditions in biological fluids or tissues. This technology has been used extensively to identify biomarkers in various cancers, nervous system diseases, cardiovascular diseases, pituitary diseases, and other diseases. The identification of biomarkers can be clinically useful for a more accurate diagnosis, prognosis, and treatment choice as well as disease monitoring. Among mass spectrometry (MS) methods, liquid chromatography- mass spectrometry (LC-MS) has been recognized as a robust metabolomics tool and has been widely applied in metabolite identification and quantification due to its high sensitivity, peak resolution, and reproducibility.

Trial Locations (1)

400042

China Chongqing The third hospital affiliated to the Third Millitary Medical University, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER